Back

AI Segmentation of Vestibular Schwannomas with Radiomic Analysis and Clinical Correlates

Milchenko, M.; Cross, K.; Smith, H.; LaMontagne, P.; Chakrabarty, S.; Varagur, K.; Chatterjee, R.; Bhuvic, P.; Kim, A.; Marcus, D.

2023-06-16 oncology
10.1101/2023.06.15.23291439 medRxiv
Show abstract

Vestibular schwannoma (VS) is a benign, slow growing tumor that may affect hearing and balance. It accounts for 7-8% of all primary brain tumors. Gamma knife radiosurgery (GKRS) is a common treatment option for VS. Magnetic resonance imaging (MRI) is employed for diagnosis, surgery planning, and follow-up of VS. Long-term follow-up determines efficacy of VS treatment. Identifying MRI-derived markers to improve management of VS is challenging. This study describes MRI processing pipeline that automatically segments VS and investigates stability and outcome predictive power of radiomic MRI features. We first preprocessed and segmented available pre-GKRS T1-weighted post-contrast MRI images in VS patients, using a Convolutional Neural Network (CNN) developed on DeepMedic framework. Then, we compared CNN and manual segmentations, extracted radiomic features from both manual and CNN segmentations of VS, and, finally, evaluated robustness of extracted features and clinical outcome analyses based thereof. We found that homogeneity, robust maximum intensity and sphericity were the most robust across segmentations. We also found that maximum and minimum intensities were most predictive of tumor growth across all segmentation methods and subject cohorts. We used retrospective post-GK SRS data collected in our institution to build the processing pipeline for unsupervised segmenting of VS. This pipeline is released as a Docker image integrated with XNAT (extensible neuroimaging archive toolkit), an established open research imaging database platform15. Generated segmentations can be viewed and edited in the XNAT-based online OHIF (Open Health Imaging Foundation) viewer16 in real time.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Neuro-Oncology Advances
24 papers in training set
Top 0.1%
41.9%
2
Scientific Reports
3102 papers in training set
Top 7%
9.7%
50% of probability mass above
3
Neuro-Oncology
30 papers in training set
Top 0.2%
4.2%
4
Journal of the Neurological Sciences
17 papers in training set
Top 0.1%
3.9%
5
PLOS ONE
4510 papers in training set
Top 37%
3.8%
6
Annals of Clinical and Translational Neurology
29 papers in training set
Top 0.4%
2.0%
7
Frontiers in Neuroscience
223 papers in training set
Top 3%
2.0%
8
Brain and Behavior
37 papers in training set
Top 0.4%
1.8%
9
Nature Communications
4913 papers in training set
Top 53%
1.6%
10
JCO Precision Oncology
14 papers in training set
Top 0.2%
1.4%
11
Scientific Data
174 papers in training set
Top 1%
1.4%
12
Neuropathology and Applied Neurobiology
14 papers in training set
Top 0.3%
1.3%
13
Diagnostics
48 papers in training set
Top 1%
1.3%
14
NeuroImage
813 papers in training set
Top 5%
1.3%
15
Clinical Cancer Research
58 papers in training set
Top 1%
0.9%
16
Annals of Biomedical Engineering
34 papers in training set
Top 1%
0.8%
17
Biology Methods and Protocols
53 papers in training set
Top 2%
0.8%
18
iScience
1063 papers in training set
Top 29%
0.8%
19
Journal of Clinical Medicine
91 papers in training set
Top 6%
0.8%
20
eLife
5422 papers in training set
Top 57%
0.8%
21
Frontiers in Oncology
95 papers in training set
Top 4%
0.7%
22
npj Precision Oncology
48 papers in training set
Top 2%
0.5%
23
BMJ Open
554 papers in training set
Top 14%
0.5%
24
Journal of Magnetic Resonance Imaging
14 papers in training set
Top 0.7%
0.5%
25
NMR in Biomedicine
24 papers in training set
Top 0.5%
0.5%
26
Medical Physics
14 papers in training set
Top 0.7%
0.5%
27
Cancers
200 papers in training set
Top 5%
0.5%
28
Brain Communications
147 papers in training set
Top 4%
0.5%